KANAYA SUSAN M 4
4 · ChemoCentryx, Inc. · Filed Aug 18, 2022
Insider Transaction Report
Form 4
KANAYA SUSAN M
SVP, Finance, CFO and Sec.
Transactions
- Exercise/Conversion
Common Stock
2022-08-16$10.86/sh+19,898$216,092→ 111,215 total - Sale
Common Stock
2022-08-16$50.95/sh−19,898$1,013,793→ 91,317 total - Exercise/Conversion
Stock Option (right to buy)
2022-08-16−19,898→ 35,102 totalExercise: $10.86Exp: 2028-03-05→ Common Stock (19,898 underlying)
Holdings
- 132,717(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $50.80 to $51.21 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]As of August 16, 2022, and prior to this transaction, the exercised options were fully vested.
- [F4]Not applicable.